Free Trial

FY2025 EPS Estimates for Methanex Lowered by Raymond James

Methanex logo with Basic Materials background

Methanex Co. (NASDAQ:MEOH - Free Report) TSE: MX - Equities researchers at Raymond James reduced their FY2025 earnings per share (EPS) estimates for Methanex in a research note issued on Tuesday, October 22nd. Raymond James analyst S. Hansen now anticipates that the specialty chemicals company will post earnings of $4.58 per share for the year, down from their prior estimate of $4.88. Raymond James has a "Outperform" rating and a $54.00 price objective on the stock. The consensus estimate for Methanex's current full-year earnings is $2.41 per share.

Methanex (NASDAQ:MEOH - Get Free Report) TSE: MX last posted its quarterly earnings data on Tuesday, July 30th. The specialty chemicals company reported $0.62 EPS for the quarter, topping analysts' consensus estimates of $0.52 by $0.10. The company had revenue of $920.00 million for the quarter, compared to analyst estimates of $954.26 million. Methanex had a return on equity of 5.44% and a net margin of 4.05%. The business's revenue was down 2.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.60 earnings per share.

Other equities research analysts also recently issued research reports about the company. Scotiabank boosted their target price on Methanex from $58.00 to $60.00 and gave the stock a "sector outperform" rating in a research report on Wednesday, July 10th. UBS Group dropped their target price on Methanex from $58.00 to $54.00 and set a "buy" rating for the company in a research report on Monday, September 16th. Royal Bank of Canada reiterated a "sector perform" rating and issued a $55.00 price objective on shares of Methanex in a report on Tuesday, September 3rd. Piper Sandler upped their price objective on Methanex from $51.00 to $68.00 and gave the company an "overweight" rating in a report on Tuesday, September 10th. Finally, Barclays lowered Methanex from an "overweight" rating to an "equal weight" rating and dropped their price target for the stock from $56.00 to $44.00 in a research report on Tuesday, September 10th. Three equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $55.38.

Get Our Latest Stock Analysis on MEOH

Methanex Price Performance

Methanex stock traded up $0.42 on Thursday, reaching $40.38. The company's stock had a trading volume of 228,273 shares, compared to its average volume of 299,180. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.87 and a current ratio of 1.25. The company has a market cap of $2.72 billion, a price-to-earnings ratio of 17.11 and a beta of 1.35. The business's fifty day moving average price is $42.31 and its 200 day moving average price is $46.68. Methanex has a twelve month low of $36.13 and a twelve month high of $56.43.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the company. Blue Trust Inc. grew its holdings in shares of Methanex by 56.8% during the third quarter. Blue Trust Inc. now owns 2,474 shares of the specialty chemicals company's stock worth $102,000 after buying an additional 896 shares in the last quarter. Dixon Mitchell Investment Counsel Inc. grew its holdings in shares of Methanex by 9.9% during the third quarter. Dixon Mitchell Investment Counsel Inc. now owns 1,182,168 shares of the specialty chemicals company's stock worth $49,022,000 after buying an additional 106,848 shares in the last quarter. Value Partners Investments Inc. grew its holdings in shares of Methanex by 10.4% during the third quarter. Value Partners Investments Inc. now owns 5,642 shares of the specialty chemicals company's stock worth $233,000 after buying an additional 532 shares in the last quarter. Clearbridge Investments LLC grew its stake in Methanex by 18.4% in the second quarter. Clearbridge Investments LLC now owns 52,350 shares of the specialty chemicals company's stock valued at $2,526,000 after purchasing an additional 8,150 shares in the last quarter. Finally, Truist Financial Corp grew its stake in Methanex by 5.0% in the second quarter. Truist Financial Corp now owns 6,219 shares of the specialty chemicals company's stock valued at $300,000 after purchasing an additional 294 shares in the last quarter. 73.49% of the stock is currently owned by institutional investors.

Methanex Company Profile

(Get Free Report)

Methanex Corporation produces and supplies methanol in China, Europe, the United States, South America, South Korea, Canada, and Asia. The company also purchases methanol produced by others under methanol offtake contracts and on the spot market. In addition, it owns and leases storage and terminal facilities.

Featured Articles

Earnings History and Estimates for Methanex (NASDAQ:MEOH)

Should you invest $1,000 in Methanex right now?

Before you consider Methanex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Methanex wasn't on the list.

While Methanex currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Post-Election Chaos or Opportunity? Prepare Your Investments
Strong Markets Meet Rising Volatility—Are Your Investments Safe?
Analysts Bullish on AI-Powered Healthcare: Intuitive Surgical’s 30% Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines